Best Practice Criteria for Pluripotent Stem Cell Lines
This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. Dr. Lyn Healy from the Francis Crick Institute gives a detailed overview of best practice criteria for pluripotent stem cell lines and provides practical advice about how to assess cell quality.
Publish Date: April 20, 2020
Views: 0
Related Multimedia
-
Nature Research Round Table: Best Practices for the QC of Genome-Edited hPSC Lines - Panel Discussion
Publish Date: November 01, 2019 -
Nature Research Round Table: hPSC Lines for Cell Therapies - Panel Discussion
Publish Date: November 01, 2019 -
Nature Research Round Table: Defining and Maintaining Pluripotency & hPSC Line Registration and Banking - Panel Discussion
Publish Date: November 01, 2019
Explore Our Products
-
STEMdiff™ Trilineage Differentiation Kit
Functional assay kit to assess pluripotency by directed differentiation of human ES and iPS cells to all three germ layers -
cGMP, enzyme-free human pluripotent stem cell selection and passaging reagent -
cGMP, stabilized feeder-free maintenance medium for human ES and iPS cells -
Defined supplement for single-cell cloning of human ES and iPS cells
